Antifungal activity from 14-helical β-peptides

Journal of the American Chemical Society

Volumn 128, Issue 39, 2006, Pages 12630-12631

  Karlsson, Amy J ^a   Pomerantz, William C ^b   Weisblum, Bernard ^b   Gellman, Samuel H ^b   Palecek, Sean P ^a  

^a University of Wisconsin Madison   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BETA PEPTIDE DERIVATIVE; MAGAININ 2 DERIVATIVE; MAGAININ DERIVATIVE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; FUNGICIDE RESISTANCE; IONIC STRENGTH; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTIDE ANALYSIS; PREVALENCE; PROTEIN SECONDARY STRUCTURE; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; MICROBIAL SENSITIVITY TESTS; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33749528779     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja064630y     Document Type: Article

References (25)

1. (a) Pappas, P. G.; Rex, J. H.; Sobel, J. D.; Filler, S. G.; Dismukes, W. E.; Walsh, T. J.; Edwards, J. E. Clin. Infect. Dis. 2004, 38, 161-189.
2. (b) Sanglard, D.; Bille, J. In Candida and candidiasis; Calderone, R. A., Ed.; ASM Press: Washington, DC, 2002.
3. (a) Hancock, R. E.; Chappie, D. S. Antimicrob. Agents Chemother. 1999, 43, 1317-1323.
4. (b) van't Hof, W.; Veerman, E. C.; Heimerhorst, E. J.; Nieuw Amerongen, A. V. Biol. Chem. 2001, 382, 597-619.
5. (a) Avrahami, D.; Shai, Y. Biochemistry 2002, 41, 2254-2263.
6. (b) Makovitzki, A.; Shai, Y. Biochemistry 2005, 44, 9775-9784.
7. (a) Hamuro, Y.; Schneider, J. P.; DeGrado, W. F. J. Am. Chem. Soc. 1999, 121, 12200-12201,
8. (b) Porter, E. A.; Wang, X.; Lee, H. S.; Weisblum, B.; Gellman, S. H. Nature 2000, 404, 565.
9. (c) Liu, D.; DeGrado, W. F. J. Am. Chem. Soc. 2001, 123, 7553-7559.
10. (d) Arvidsson, P. I.; Frackenpohl, J.; Ryder, N. S.; Liechty, B.; Petersen, F.; Zimmermann, H.; Camenisch, G. P.; Woessner, R.; Seebach, D. Chembiochem 2001, 2, 771-773.
11. (e) LePlae, P. R.; Fisk, J. D.; Porter, E. A.; Weisblum, B.; Gellman, S. H. J. Am. Chem. Soc. 2002, 124, 6820-6821.
12. (f) Porter, E. A.; Weisblum, B.; Gellman, S. H. J. Am. Chem. Soc. 2002, 124, 7324-7330.
13. (g) Raguse, T. L.; Porter, E. A.; Weisblum, B.; Gellman, S. H. J. Am. Chem. Soc. 2002, 124, 12774-12785.
14. (h) Porter, E. A.; Weisblum, B.; Gellman, S. H. J. Am. Chem. Soc. 2005, 127, 11516-11529.
15. Wisplinghoff, H.; Bischoff, T.; Tallent, S. M.; Seifert, H.; Wenzel, R. P.; Edmond, M. B. Clin. Infect. Dis. 2004, 39, 309-317.
16. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard, 2nd ed.; NCCLS document M27-A2; National Committee for Clinical Laboratory Standards: Wayne, PA, 2002.
17. Lee, I. H.; Cho, Y.; Lehrer, R. I. Infect. Immun. 1997, 65, 2898-2903.
18. Heimerhorst, E. J.; Reijnders, I. M.; van't Hof, W.; Veerman, E. C.; Nieuw Amerongen, A. V. FEBS Lett. 1999, 449, 105-110.
19. Chen, H. C.; Brown, J. H.; Morell, J. L.; Huang, C. M. FEBS Lett. 1988, 236, 462-466.
20. (a) Bessalle, R.; Kapitkovsky, A.; Gorea, A.; Shalit, I.; Fridkin, M. FEBS Lett. 1990, 274, 151-155.
21. (b) Wade, D.; Boman, A.; Wahlin, B.; Drain, C. M.; Andreu, D.; Boman, H. G.; Merrifield, R. B. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 4761-4765.
22. (a) Appella, D. H.; Barchi, J. J.; Durell, S. R.; Gellman, S. H. J. Am. Chem. Soc. 1999, 121, 2309-2310.
23. (b) Raguse, T. L.; Lai, J. R.; Gellman, S. H. J. Am. Chem. Soc. 2003, 125, 5592-5593.
24. CD data for 1-5 may be found in the Supporting Information.
25. Raguse, T. L.; Lai, J. R.; LePlae, P. R.; Gellman, S. H. Org. Lett. 2001, 3, 3963-3966.